Segall Bryant & Hamill LLC Has $1.44 Million Stake in AdvanSix Inc. (NYSE:ASIX)

Segall Bryant & Hamill LLC lifted its holdings in shares of AdvanSix Inc. (NYSE:ASIX) by 299.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 50,601 shares of the company’s stock after purchasing an additional 37,940 shares during the quarter. Segall Bryant & Hamill LLC owned 0.19% of AdvanSix worth $1,442,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of the business. Intech Investment Management LLC bought a new stake in AdvanSix in the 3rd quarter valued at $274,000. FMR LLC raised its stake in shares of AdvanSix by 86.2% in the 3rd quarter. FMR LLC now owns 565,982 shares of the company’s stock valued at $17,195,000 after purchasing an additional 261,964 shares during the period. Quantbot Technologies LP lifted its holdings in shares of AdvanSix by 618.5% in the third quarter. Quantbot Technologies LP now owns 4,361 shares of the company’s stock valued at $132,000 after purchasing an additional 3,754 shares in the last quarter. BNP Paribas Financial Markets boosted its position in shares of AdvanSix by 120.0% during the third quarter. BNP Paribas Financial Markets now owns 18,855 shares of the company’s stock worth $573,000 after buying an additional 10,284 shares during the period. Finally, Centiva Capital LP bought a new position in shares of AdvanSix during the third quarter worth about $315,000. Institutional investors own 86.39% of the company’s stock.

AdvanSix Stock Down 2.1 %

ASIX stock opened at $22.57 on Friday. The company has a market cap of $603.61 million, a price-to-earnings ratio of 14.02 and a beta of 1.73. AdvanSix Inc. has a twelve month low of $20.86 and a twelve month high of $33.00. The business has a 50 day moving average price of $27.84 and a two-hundred day moving average price of $29.09. The company has a quick ratio of 0.49, a current ratio of 1.08 and a debt-to-equity ratio of 0.25.

AdvanSix (NYSE:ASIX) last released its earnings results on Friday, February 21st. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.37) by $0.40. The business had revenue of $329.06 million during the quarter, compared to analysts’ expectations of $377.15 million. AdvanSix had a net margin of 2.91% and a return on equity of 6.26%. Analysts anticipate that AdvanSix Inc. will post 4 EPS for the current fiscal year.

AdvanSix Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 24th. Stockholders of record on Monday, March 10th were paid a dividend of $0.16 per share. The ex-dividend date was Monday, March 10th. This represents a $0.64 annualized dividend and a dividend yield of 2.84%. AdvanSix’s dividend payout ratio is presently 39.75%.

Insider Activity

In related news, CEO Erin N. Kane sold 5,000 shares of the business’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $28.15, for a total transaction of $140,750.00. Following the transaction, the chief executive officer now directly owns 507,795 shares of the company’s stock, valued at approximately $14,294,429.25. The trade was a 0.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.60% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on ASIX shares. Piper Sandler reduced their price target on AdvanSix from $39.00 to $35.00 and set an “overweight” rating for the company in a research report on Tuesday, March 18th. UBS Group set a $35.00 target price on shares of AdvanSix in a report on Tuesday, March 18th. Finally, StockNews.com lowered shares of AdvanSix from a “buy” rating to a “hold” rating in a research note on Monday, March 24th.

AdvanSix Profile

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.